By using pre-determined change control plans, manufacturers can update AI-enabled devices without filing an additional FDA ...

Breaking Out is a technical analysis-fuelled, short ‘n’ sharp take on chart-busting ASX stocks. Each week, Steve Collette – head of Collette Capital in Melbourne – narrows in on something that’s ...

Withings announced that it received approximately $22.5 million in investment and support for a new initiative from the ...

Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who ...

From new clinical data to product launches, here are five key developments from spine and orthopedic devicemakers since Nov. 27.

A hospital in Texas announced that its electrophysiologists completed the first U.S. cases with the Medtronic (NYSE:MDT) ...

Selling the assets to Italy’s GVS should help Haemonetics improve its revenue growth and profit margins, analysts said.

More than half of survey respondents reported using an AI algorithm for at least one imaging use case, compared with just 17% ...

During this session, the panelists discussed notable developments within the life sciences industry with a specific focus on the GLP-1 drug market ...

Avania, the leading global MedTech advisory and clinical development partner, today announced the appointment of operational strategy expert Charlene Dark as chief operating officer (COO). Avania, the ...

OpenText stock may be known for its tech innovations, but it's also a top dividend stock that investors should snap up. The post Down 22%, This Magnificent Dividend Stock Is a Screaming Buy appeared ...